http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_891667d3bb7b75695bc2577757743e57
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Ballestar |
| name | Esteban Ballestar |
| given-name | Esteban |
| organization-name | Epigenetics and Immune Disease Group Josep Carreras Research Institute (IJC) Barcelona Spain Epigenetics and Immune Disease Group , Josep Carreras Research Institute (IJC) , Badalona , Barcelona , Spain; Epigenetics in Inflammatory and Metabolic Diseases Laboratory , Health Science Center (HSC) , East China Normal University (ECNU) , Shanghai , China Laboratory of Molecular Embryology, National Institute of Child Health and Human Development, National Institutes of Health, Building 18T, Room 106, Bethesda, Maryland 20892-5431, and Department of Genetics, The George Washington University, 2121 I Street NW, Washington, D.C. 20052 Bellvitge Biomedical Research Institute Barcelona Spain *Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain; and Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain. 1Cancer Epigenetics Laboratory, Spanish National Cancer Centre, Madrid, Spain and Cancer Epigenetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain Chromatin and Disease Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain Cancer Epigenetics Group, Molecular Pathology Programme, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain. Chromatin and Disease Group Cancer Epigenetics and Biology Programme (PEBC) Bellvitge Biomedical Research Institute (IDIBELL) L'Hospitalet de Llobregat Barcelona Spain 1Cancer Epigenetics and Biology Program and 2Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, L'Hospitalet, and 3Institució Catalana de Recerca i Estudis Avançats, Catalonia, Spain; and 4First Department of Internal Medicine, Sapporo Medical University School of Medicine and 5Sapporo Medical University, Sapporo, Japan Chromatin and Disease Group, Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, 08908 L’Hospitalet, Barcelona, Spain 2 Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Madrid, Spain Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Melchor Fernandez Almagro 3, 28029 Madrid, Spain. 1Cancer Epigenetics Laboratory, Spanish National Cancer Research Centre, Madrid, Spain; Epigenetics, Cytogenetics, and Genetic Laboratories, Spanish National Cancer Centre (CNIO), Melchor Fernandez Almagro 3, 28029 Madrid, Spain; Department of Behavioral Science, University of Valencia, 46010 Valencia, Spain; Molecular Genetics Laboratory, Genetics Department, Son Dureta Hospital, 07014 Palma de Mallorca, Spain; Department of Clinical Sciences, University Hospital Malmö, Lund University, S-205 02 Malmö, Sweden; Steno Diabetes Center, 2820 Gentofte, Denmark; Twin Research and Genetic... Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Madrid, Spain; Cancer Epigenetics Laboratory, Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, 28029 Madrid, Spain. Spanish National Cancer Centre, Madrid, Spain Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC) , 08916 Badalona, Spain; Germans Trias i Pujol Research Institute (IGTP) , 08916 Badalona, Spain Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), IDIBELL, Barcelona, Spain. [email protected] Authors' Affiliations: 1Chromatin and Disease Group and 2Cancer Epigenetics Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; 3Broad Institute, Cambridge; 4Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Brookline, Massachusetts; 5Bioinformatics Unit and Structural Biology and Biocomputing Programme, Spanish National Cancer Centre, Madrid; 6Hematology Department and Area of Cell Therapy, Clínica Universidad de Navarra, Foundation for Applied Medical Research, 7Hematology Department, Reina Sofia Hospital, Cordoba; 8Department of Genetics, School of Sciences, University of Navarra, Pamplona; and 9Molecular Medicine Unit-Department of Medicine, Center for Cancer Research, University of Salamanca, Salamanca, Spain 1Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Centre, Madrid, Spain; Department of Biochemistry and Molecular Biology, University of Valencia, E-46100 Burjassot, Valencia, Spain Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre, Madrid, Spain |
Incoming Links
Showing number of triples: 1 to 150 of 150.